MIBC Survival Appears Superior After NAC+RC vs Trimodality Therapy

This study is among the first to compare trimodality therapy with neoadjuvant chemotherapy added to radical cystectomy. A study probed the efficacy of neoadjuvant chemo (NAC) plus RC vs trimodality therapy for muscle-invasive bladder cancer (MIBC).

Related Keywords

Skye Chen ,Jiangsu ,China ,Sichuan ,Gansu , ,European Journal Of Medical Research ,Sichuan University ,End Results ,West China Hospital ,European Journal ,